Aobiome LLC | MedPath

Rosacea Therapeutics Pipeline Shows Promise with Emerging Therapies

4 months ago

• Over 25 companies are developing novel rosacea treatments, indicating a robust pipeline. • Key emerging therapies like Epsolay, M 1220, and BMX-010 are expected to significantly impact the rosacea market. • Sol-Gel Technologies and Maruho Co., Ltd. are among the leading companies in developing advanced-stage rosacea drugs. • Recent regulatory approvals, such as Zydus Lifesciences' metronidazole topical cream, offer new treatment options.

Rosacea Therapeutics: Emerging Therapies and Market Outlook

7 months ago

• Over 25 companies are actively involved in developing novel rosacea treatments, indicating a robust pipeline. • Key emerging therapies like Epsolay, M 1220, and BMX-010 are expected to significantly impact the rosacea market in the coming years. • Sol-Gel Technologies and Maruho Co., Ltd. are among the leading companies in advancing rosacea drug candidates through clinical development. • Recent regulatory approvals, such as Zydus Lifesciences' metronidazole topical cream, provide additional treatment options for rosacea patients.

Rosacea Pipeline Analysis 2024: Insights into Therapeutics Development

a year ago

The 2024 Rosacea Pipeline Analysis report by DelveInsight highlights the ongoing clinical development activities and growth prospects in the Rosacea Therapeutics Market. It details the involvement of over 25 key pharma and biotech companies, including Sol-Gel Technologies, in developing more than 25 pipeline drugs. The report covers various stages of clinical development, mechanisms of action, and molecule types, offering a comprehensive overview of the current and future landscape of Rosacea treatment.